Kopran (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Kopran Limited |
|||
|
Price: ₹215.29 | ||
| 52 Week Low: ₹198.00 52 Week High: ₹369.70 |
|||
| Market Capital: 1,091.73 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - General | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Kopran Share Price Target For 2024
- 1.1.1: Kopran Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Kopran Share Price Target For 2025
- 1.2.1: Kopran Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Kopran Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Kopran Brief Company Overview
- 4: Kopran Financial Performance
- 4.0.1: Is Kopran A Good Buy For Long Term?
To predict the Kopran's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Kopran Share Price Target For 2024
The line chart displays the monthly closing prices of Kopran with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Kopran shares in 2024, see the table below.
Kopran Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 224.05 (+4.05%) | Price Action: 30 May 2024 Low |
| 2024 Target 2 | 221.8 (+3.02%) | Price Action: May 2024 Low |
| 2024 Target 1 | 219.4 (+1.9%) | Price Action: Jul 2022 High |
| Current Price | 215.29 | Kopran's share price as of 26 Dec 2024 |
| Stop Loss 1 | 213.41 (-0.88%) | Price Action: 06 Dec 2024 Low |
| Stop Loss 2 | 211.2 (-1.9%) | Price Action: 13 Mar 2024 Low |
| Stop Loss 3 | 209.08 (-2.89%) | Price Action: Mar 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Kopran is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹215.04 serves as the nearest technical reference point.
Historical Returns: 3-month: -34.36% | 6-month: -14.19% | 1-year: -9.86%
Kopran Share Price Target For 2025
The line chart displays the monthly closing prices of Kopran with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Kopran shares in 2025, see the table below.
Kopran Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 325.57 (+51.22%) | Fibonacci Extension Level 64.90% |
| 2025 Target 2 | 321.25 (+49.21%) | Price Action: 22 Aug 2024 High |
| 2025 Target 1 | 317.6 (+47.52%) | Price Action: 07 Oct 2024 High |
| Current Price | 215.29 | Kopran's share price as of 26 Dec 2024 |
| Stop Loss 1 | 189.05 (-12.19%) | Price Action: Sep 2022 High |
| Stop Loss 2 | 186.4 (-13.42%) | Price Action: 08 Aug 2023 High |
| Stop Loss 3 | 184.35 (-14.38%) | Price Action: 09 Aug 2023 High |
Long-Term Technical Outlook
52-Week Range Analysis: Kopran is currently trading near its 52-week low of ₹198, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -9.86% | 3-year: -33.5% | 5-year: +592.25%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Kopran Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹215.29 | ||
| 2024 | ₹263.43 | +22.36% | ₹267.38 |
| 2025 | ₹296.48 | +12.54% | ₹316.30 |
| 2026 | ₹347.47 | +17.19% | ₹352.68 |
| 2027 | ₹370.58 | +6.65% | ₹376.14 |
| 2028 | ₹380.33 | +2.63% | ₹386.03 |
| 2029 | ₹373.78 | -1.72% | ₹409.80 |
| 2030 | ₹411.07 | +9.97% | ₹440.97 |
| 2031 | ₹472.13 | +14.85% | ₹479.21 |
| 2032 | ₹494.63 | +4.76% | ₹502.05 |
| 2033 | ₹499.65 | +1.01% | ₹507.14 |
| 2034 | ₹484.12 | -3.1% | ₹534.47 |
| 2035 | ₹525.66 | +8.58% | ₹565.63 |
| 2036 | ₹596.80 | +13.53% | ₹605.75 |
| 2037 | ₹618.68 | +3.66% | ₹627.96 |
| 2038 | ₹618.98 | +0.04% | ₹628.26 |
| 2039 | ₹561.76 | -9.24% | ₹659.13 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Kopran Brief Company Overview
Kopran Limited: A Leader in Pharmaceuticals Established in 1958 and headquartered in Mumbai, India, Kopran Limited is a well-respected pharmaceutical company with a global reach. The company manufactures and sells a comprehensive range of products, including active...
pharmaceutical ingredients and finished dosage forms. Kopran's diverse product portfolio includes tablets, capsules, syrups, dry powder, suspension, injectables, and topical preparations. The company specializes in various therapeutic categories, such as macrolide, antibacterial, anticonvulsant, and anti-hypertensive. Kopran is committed to providing high-quality and affordable healthcare solutions. The company has a strong reputation within the industry for its commitment to innovation and research.Kopran Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,091.73 Crore | Market valuation of Kopran's shares. |
| Revenue (TTM) | 637.1 Crore | Total revenue generated by Kopran over the past twelve months. |
| Net Income (TTM) | +52.89 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +7.78% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +8.3% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-25.07% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-46.41% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
24.95 | Company's total debt divided by total shareholder equity. |
| Total Debt | 124.12 Crore | Sum of Kopran's current & long-term financial obligations. |
| Total Cash | 8.3 Crore | Total amount of liquid funds available to Kopran. |
Is Kopran A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
